Significant Ownership of Bihua Chen
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bihua Chen focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Bihua Chen - Chen Bihua
- Manager location
- Boston, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bihua Chen and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Bihua Chen
Significant Ownership of Bihua Chen
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HLXB | Helix Acquisition Corp. II | Class A ordinary shares, $0.0001 par value per share | 32% | $81,352,890 | 7,389,000 | Bihua Chen | 28 Feb 2025 | ||
| HLXB | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 23% | 17,878,594 | Bihua Chen | 11 Aug 2025 | |||
| MLTX | MoonLake Immunotherapeutics | Class A Ordinary Shares | 3.1% | $108,084,177 | 1,994,173 | Chen Bihua | 30 Sep 2025 | ||
| BMEA | Biomea Fusion, Inc. | Common Stock | 1.5% | $2,143,436 | -$5,295,734 | 1,060,792 | -71% | Chen Bihua | 22 Oct 2025 |
Schedules 13D/G Reported by Bihua Chen:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.